Perspective - (2025) Volume 16, Issue 3
Metabolism, Intermittent, Health, Physiology, Biomedicine
The study of metabolism has garnered increasing attention as researchers recognize its central role in both health maintenance and disease prevention. In this context, intermittent fasting (IF) has emerged as a promising non-pharmacological strategy to improve metabolic health. Unlike traditional caloric restriction, IF involves cycling between periods of eating and fasting, without necessarily reducing overall caloric intake. This approach has been found to influence weight regulation, insulin sensitivity, lipid metabolism, and cellular health. “Intermittent Fasting and Its Impact on Metabolic Health” explores this promising area, which reflects the complex interaction between genetics, lifestyle, and environmental triggers in metabolic regulation. The goal of this article is to elucidate the physiological basis of IF and assess its application in clinical and preventive medicine.
Intermittent fasting influences several core biological systems, including metabolic pathways, hormonal regulation, circadian rhythms, cellular stress responses, and gut microbiota composition. These changes occur in response to fasting-induced metabolic switching from glucose to fatty acid-derived ketones as the primary energy source. This switch initiates multiple downstream effects, such as increased autophagy, reduced oxidative stress, and enhanced mitochondrial efficiency. IF modulates insulin and glucagon levels, promoting improved insulin sensitivity and glycemic control. It also affects leptin and ghrelin secretion, which play vital roles in hunger signaling and satiety [1]. Fasting activates AMP-activated protein kinase (AMPK) and inhibits the mammalian target of rapamycin (mTOR), both of which are key regulators of cellular growth and metabolism [2]. These signaling changes can lead to improved lipid profiles and enhanced glucose utilization. Aligning fasting periods with the body's circadian rhythm amplifies metabolic benefits. Studies suggest that early time-restricted feeding may synchronize eating patterns with natural biological clocks, thus improving outcomes [3]. Gut microbiota composition is also modulated by fasting, promoting beneficial bacteria that support intestinal and systemic health [4]. Individual genetic variability significantly influences metabolic responses to fasting. Interventions tailored to genetic profiles—such as those targeting PPAR-γ, FTO, or SIRT1 gene variants—can enhance treatment effectiveness [5].
The evidence points to the considerable promise of intermittent fasting as a metabolic intervention. Its ability to restore metabolic homeostasis via multiple pathways makes it a compelling alternative to pharmacological therapies, particularly in early-stage metabolic disorders.
Clinical applications
IF could be applied as a frontline non-invasive therapy in managing type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), and polycystic ovary syndrome (PCOS). Clinicians may use fasting regimens in combination with lifestyle modifications to achieve better long-term metabolic outcomes.
Challenges and limitations
Despite its promise, several challenges must be addressed:
Intermittent fasting represents a promising frontier in metabolic health. By leveraging the body’s intrinsic capacity for metabolic switching and repair, it offers a pathway to prevent and manage chronic metabolic disorders. Its influence spans molecular, hormonal, and systemic levels, underscoring its potential for wide-ranging clinical applications. With continued research, particularly long-term and large-scale trials, intermittent fasting may play a transformative role in personalized health care and preventive medicine.
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Received: 01-Mar-2025, Manuscript No. jdm-25-37748; Editor assigned: 03-Mar-2025, Pre QC No. jdm-25-37748(PQ); Reviewed: 17-Mar-2025, QC No. jdm-25-37748; Revised: 21-Mar-2025, Manuscript No. jdm-25-37748(R); Published: 28-Mar-2025
Copyright: © 2025 Kulkarni MS. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
